GNOM
ETF / Mutual Fund
NASDAQ
Global X Genomics & Biotechnology ETF
$8.23
-$1.48 (-15.20%)
Price Chart
Overview
About GNOM
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
AUM
Volume
729.3K
Avg. Volume
529.3K
Expense Ratio
0.50%
Fund Information
Exchange
NASDAQ
Sector
Risk & Correlation Analysis
Market Correlation
1.06
Moderate Correlation
Volatility
Medium (0.29)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, GNOM shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
AUM
Volume729.3K
Expense Ratio0.50%
Important Dates
Next Dividend
Next Earnings
Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025